Sravan Kumar Emany - 31 Jan 2026 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: Chief Financial Officer
Signature: By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol: BEAM
Transactions as of: 31 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 02 Feb 2026, 16:05:13 UTC
Previous filing: 05 Jan 2026
Next filing: 26 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Emany Sravan Kumar	Chief Financial Officer	C/O BEAM THERAPEUTICS INC.,, 238 MAIN STREET, CAMBRIDGE	By: /s/ Christine Bellon, Attorney-in-fact	02 Feb 2026	0001897662

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BEAM	Stock Option (Right to Buy)	Award	$0	+63,500		$0.000000	63,500	31 Jan 2026	Common Stock	63,500	$27.62	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date.